Document is current
Any future updates will be listed below
-
Authors
Masanam, Monika K.
Kantor, Olga
Pappas Brunco, Olivia
Faust, Amanda C.
Tappan, Lila
Harvey, Maria E.
Dudman, Caroline G.
Block, Caroline C.
Bychkovsky, Brittany L.
Bellon, Jennifer R.
Mittendorf, Elizabeth A.
King, Tari A.
- License Information
-
More Information
Article History
Received: 17 September 2025
Accepted: 2 January 2026
First Online: 22 January 2026
Disclosure
: Elizabeth A. Mittendorf reports compensated service on scientific advisory boards for AstraZeneca, BioNTech, Merck, and Moderna; uncompensated service on steering committees for Bristol Myers Squibb and Roche/Genentech; speaker honoraria and travel support from Merck Sharp & Dohme; and institutional research support from Roche/Genentech (via SU2C grant) and Gilead. She also resports research funding from Susan Komen for the Cure, for which she serves as a Scientific Advisor, and uncompensated participation as a member of the American Society of Clinical Oncology Board of Directors. Tari A. King reports speaker honoraria for Exact Sciences, compensated service on the FES Steering Committee for GE Healthcare, compensated service for advisory board role for Veracyte and Ataraxis AI, and compensated service as faculty for PrecisCa cancer information service. The remaining authors have no conflicts of interest.
